Paul Leber
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 5
-
- Pain Management and Placebo Effect 4
- Co-authors
- Elizabeth M. Ryan (1 shared paper)Harvey M. Levy (1 shared paper)Charles S. Davis (1 shared paper)Shun Shimohama (2 shared papers)Martin L. Milgrom (1 shared paper)Stanley Cohen (1 shared paper)L. J. Thal (2 shared papers)Richard C. Mohs (1 shared paper)
- Journals
- Controlled Clinical Trials (1 paper)International Psychogeriatrics (1 paper)Epilepsia (1 paper)Journal of Biological Chemistry (1 paper)Alzheimer Disease & Associated Disorders (1 paper)
- Partner nations
- United States
In The Last Decade
Paul Leber
22 papers receiving 793 citations
Peers
Comparison fields: 5 of 102
- Psychiatry and Mental health 167
- Biochemistry 70
- Pharmacology 104
- Clinical Biochemistry 42
- Biotechnology 56
Countries citing papers authored by Paul Leber
This map shows the geographic impact of Paul Leber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Leber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Leber more than expected).
Fields of papers citing papers by Paul Leber
This network shows the impact of papers produced by Paul Leber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Leber. The network helps show where Paul Leber may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Leber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1963 | 391 | |
| 2 | 1989 | 95 | |
| 3 | Slowing the progression of Alzheimer disease: methodologic issues. | 1997 | 75 |
| 4 | 1998 | 68 | |
| 5 | 1996 | 58 | |
| 6 | 2000 | 33 | |
| 7 | Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. | 1997 | 28 |
| 8 | Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. | 1997 | 25 |
| 9 | The placebo control in clinical trials (a view from the FDA). | 1986 | 23 |
| 10 | Is there an alternative to the randomized controlled trial? | 1991 | 21 |
| 11 | 1973 | 15 | |
| 12 | Adverse drug reactions. Safe passage (how good a guarantee?). | 1982 | 13 |
| 13 | Speed of onset. | 1995 | 10 |
| 14 | Lithium leukocytosis, and leukemia: the probable influence of biologic plausibility on clinical concern. | 1981 | 6 |
| 15 | Challenges to the ethicality of clinical research. | 1996 | 6 |
| 16 | Sudden death as a risk of neuroleptic treatment: (a continuing controversy). | 1981 | 5 |
| 17 | 1990 | 3 | |
| 18 | 2009 | 2 | |
| 19 | Psychotherapeutic Medications Development Program (PMDP) Workshop on NMDA Receptor Antagonists: neurotoxicity evaluation. Introduction. | 1994 | 2 |
| 20 | 1996 | 1 |
About Paul Leber
Paul Leber is a scholar working on Economics and Econometrics, Cognitive Neuroscience, Physiology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 22 papers that have together received 882 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Pain Management and Placebo Effect (4 papers), Treatment of Major Depression (3 papers), Statistical Methods in Clinical Trials (2 papers), Biomedical Ethics and Regulation (2 papers), Pharmaceutical studies and practices (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Psychiatry and Mental health (167 citations), Biochemistry (70 citations), Pharmacology (104 citations), Clinical Biochemistry (42 citations) and Biotechnology (56 citations). Paul Leber has collaborated with scholars based in United States. Frequent co-authors include Elizabeth M. Ryan, Harvey M. Levy, Charles S. Davis, Shun Shimohama, Martin L. Milgrom, Stanley Cohen, L. J. Thal, Richard C. Mohs, Christopher Silber and Rachelle S. Doody. Their work appears in journals such as Controlled Clinical Trials, International Psychogeriatrics, Epilepsia, Journal of Biological Chemistry and Alzheimer Disease & Associated Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.